Inhibition of PD-L1 palmitoylation, either pharmacologically or by genetic ablation of DHHC3, was able to increase the T cell cytotoxicity against cancer cells in vitro, and to reduce tumour growth also in vivo. The gene discussed is CD274; the disease is cancer.